Amarin Corp. PLC ADR | Mutual Funds
Mutual Funds that own Amarin Corp. PLC ADR
Oppenheimer International Small Company Fund
7,834,530
2.67%
0
0.24%
02/28/2018
ClearBridge Special Investment Trust
3,667,889
1.25%
0
0.98%
01/31/2018
iShares Nasdaq Biotechnology ETF
3,359,969
1.14%
-43,932
0.11%
09/06/2018
Fidelity Series Small Cap Opportunities Fund
1,886,553
0.64%
893,453
0.09%
04/30/2018
Invesco Global Health Care Fund
1,362,354
0.46%
1,362,354
0.31%
06/29/2018
Highland Long/Short Healthcare Fund
1,111,399
0.38%
661,399
2.71%
12/31/2017
Fidelity Small Cap Growth Fund
953,466
0.33%
-6,299
0.07%
04/30/2018
Ohio National - Capital Growth Portfolio
890,090
0.3%
-103,830
0.99%
03/31/2018
Fidelity Select Biotechnology Portfolio
772,831
0.26%
0
0.03%
07/31/2018
Tekla Healthcare Investors
664,303
0.23%
664,303
0.19%
12/31/2017
| Address |
2 Pembroke House
Dublin Dublin 2
Ireland
|
|
Employees
|
- |
| Website |
http://amarincorp.com |
| Updated |
07/08/2019 |
| Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It's product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. |
